Continuous Ambulatory Peritoneal Dialysis in the USA : Final Report of the National CAPD Registry 1981–1988

The Final Report of the USA CAPO Registry summarizes eight years of observation and analysis that reflects the experiences of 485 clinical centers and over 25,000 CAPO patients. As such, it offers a wealth of information, available here for the first time to interested parties around the world. Because the National Institutes of Health was quick to see the potential of CAPO as a promising therapy for patients with end stage renal disease, the Registry project was begun soon after its introduction into clinical practice in the USA. Accordingly, the Registry offered the nephrology community in the United States a special opportunity to study this emerging new therapy in some detail, an opportunity not previously available for any other form of dialysis. As will be seen in this report, the result of this early and intensive research effort has been the development of a vast amount of clinically important information regarding the utilization, safety, and efficacy of this important dialytic therapy. Front Matter....Pages i-xiv Front Matter....Pages 1-1 Introduction....Pages 3-6 Front Matter....Pages 7-7 Registry Patient Population....Pages 9-15 Front Matter....Pages 17-17 Patient Characteristics....Pages 19-26 Front Matter....Pages 27-27 Complications of Treatment....Pages 29-39 Front Matter....Pages 41-41 Termination of Continuous Peritoneal Dialysis....Pages 43-60 Front Matter....Pages 61-61 A Survey of Diabetics in the CAPD/CCPD Population....Pages 63-73 Hematocrit Values in the CAPD/CCPD Population....Pages 75-81 Timing and Characteristics of Multiple Peritonitis Episodes....Pages 83-91 Geographical Distribution of Registry Coverage....Pages 93-100 Characteristics and Treatment Course of Long-term CAPD/CCPD Patients....Pages 101-107 Front Matter....Pages 109-109 Update on Children Who Use CAPD/CCPD....Pages 111-116 First Exchange Device and Peritonitis among CAPD Patients....Pages 117-123 Follow-up of Transfer from CAPD/CCPD....Pages 125-137 Pediatric Population Evaluation....Pages 139-156 Complications of Peritoneal Catheters....Pages 157-166 The Effects of CAPD on Hypertension Control....Pages 167-175 Front Matter....Pages 177-177 Introduction to Special Reports A-C: Factors Associated with Morbidity and Mortality among Patients on CAPD....Pages 179-180 Factors Associated with First Hospitalization for CAPD-Related Complications....Pages 181-188 Factors Associated with Transfer off CAPD....Pages 189-198 Factors Associated with Death While on CAPD....Pages 199-208 Front Matter....Pages 177-177 Trends in the Occurrence of Complications and of Treatment Outcomes....Pages 209-215 Variation in Treatment Outcome According to Center Size....Pages 217-221 Variation in Treatment Outcome According to Treatment and Patient Characteristics....Pages 223-228 Some Additional Factors Associated with Transfer off CAPD....Pages 229-232 Characteristics of Patients Who Received a Kidney Transplant, Whose Kidney Funciton Returned, or Who Discontinued CAPD without Return of Kidney Function....Pages 233-235 Comparison of outcomes for patients with and without prior ESRD therapy....Pages 237-239 Front Matter....Pages 241-241 Prognostic Factors Associated with the First Episode of Peritonitis....Pages 243-252 Front Matter....Pages 253-253 Considerations in Analysis of Complications....Pages 255-273 Back Matter....Pages 275-306